Presentation is loading. Please wait.

Presentation is loading. Please wait.


Similar presentations

Presentation on theme: "NATIONAL CANCER INSTITUTE AIIMS, NEW DELHI (JHAJJAR CAMPUS)"— Presentation transcript:


2 BACKGROUND Cancer Burden in India Approx. 28 lakh cancer patients at any given point of time About 11 lakh new cases occur every year Nearly 5 lakh patients die due to the cancer each year Recent technological advances in genomics and the molecular sciences have opened new vistas to accelerate knowledge about the genetic and environmental components of cancer initiation promotion and progression through studies in molecular epidemiology. However, many unanswered questions still remain in the quest to conquer this deadly disease

3 NATIONAL CANCER INSTITUTE AIIMS – NEW DELHI Apex cancer hospital and translational research facility Located at Jhajjar Campus of AIIMS, New Delhi Spread over 31.2 acre site within the 300 acre campus Project Cost : Rs. 2035 Crores Total Beds: 710 200 clinical beds 400 research beds 110 ICU beds Project approved by Union Cabinet on 26 th December 2013 Expected Commissioning : October 2017

4 NATIONAL CANCER INSTITUTE (NCI) NCI will be the premier institute of cancer, identify priority areas for Research & Development and related areas, will carry out basic and applied research in molecular biology, genomics, proteomics, cancer epidemiology, radiation biology, cancer vaccines etc. NCI will evolve model cancer control strategies which will include newer modalities of prevention, early diagnosis and therapy. It will also act as a center for development of human resource in various branches of cancer management depending on the needs of our country.

5 Urgent need to understand the various causes specific to our country, example- lifestyle, hygiene, tobacco, food habits, genetics etc Improvements in management of various cancers like Cervix and Head and Neck would have to be developed within India as they have ceased to be important for developed nations. Results of treatment in advanced stages of most malignancies continues to be dismal, and there is an ever increasing need to improve upon these. Why it is important have a center for cancer research

6 AIMS To plan, conduct and co-ordinate cancer related research for understanding, detecting, diagnosing and treating cancer. Translate this knowledge to develop feasible strategies to improve cancer care services and the quality of life of patients.

7 OBJECTIVES To act as the principal agency of the country for promoting, coordinating and conducting innovative research and the development of novel interventions to prevent and treat cancer.  Emphasis on Need Based Research. To carry out translational research and incorporate newly developed techniques in cancer therapy into clinical practice. To undertake clinical trials of newer drugs as well as vaccines to treat and improve the existing outcomes of therapy on survival and quality of life of patients. To facilitate the development of affordable medicines and equipments.

8 OBJECTIVES Set standards for cancer treatment and to evolve, update and disseminate evidence based guidelines to promote uniform patient care across the country. Develop and support training programs and generate trained human resources in all areas of cancer. Support and co-ordinate quality cancer research in Regional Cancer Centers, other governmental and non governmental agencies. Improve and harmonize standardized protocols, quality of treatment, research and education in cancer across the country.

9 OBJECTIVES To create international linkages with major cancer centers for exchanging cancer related information. To establish a collaborative network with voluntary cancer organizations. To create and disseminate credible databases of cancer incidence, epidemiology, treatment, mortality etc. To translate the knowledge to evolve National Cancer Control Policies and Programs to improve the quality of services and quality of life of cancer patients.

10 PROPOSED FACILITIES Clinical Division Research Division Disease Management Group Other Facilities

11 A CLINICAL DIVISIONS: 1.Surgical Oncology 2.Radiation Oncology 3.Medical Oncology 4.Radiology 5.Nuclear Medicine 6.Tumor Patho-biology 7.Lab medicine 8.Anesthesiology and Hospice 9.Preventive Oncology 10.Medical Physics 11.Hospital administration 12.Psycho-oncology 13.Palliative care & Hospice 14.Blood bank 15.Emergency 16. Physiotherapy &Occupational Therapy

12 B RESEARCH DIVISIONS: 1.Bioethics & Bio-safety Division 2.Cancer Epidemiology 3.Molecular Oncology 4.Cancer Genomics & Proteomics 5.Cancer Vaccine & Immunotherapy 6.Drug designing & Drug development 7.Development of Medical tools & Diagnostics 8.Pharmaco-genonics & Drug Discovery 9.Occupational Cancer Research 10.Radiobiology & Radiation Research 11.Human Resource Development in oncology 12.Translational Research 13. Biostatistics & Bioinformatics 14. Animal House 15. Tissue repository

13 NATIONAL RESEARCH COLLABORATIONS NCI has entered into MoU’s with: Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India and Institute of Cytology Preventive Oncology (ICPO), an autonomous institute under Department of Health Research, Ministry of Health and Family Welfare, Govt. of India

14 SALIENT POINTS: MOU WITH DBT & ICPO Identify areas of research: immediate, medium and long- term planning Evolve consensus mechanism to harmonize administrative and financial processes and approvals Scientific Research collaborations in the area of Cancer Biology to promote development of new affordable technologies, introduction of the available technologies in the system and provide support for diffusion of the technologies into the social system. Co-design and Co-develop research labs / facilities at National Cancer Institute (NCI) located at AIIMS-Jhajjar campus, for the purpose of Cancer Prevention/Research Training of man-power by offering joint fellowships, trainings, etc. Co-creating a state-of-the art Bio-bank with well annotated specimens

15 INTERNATIONAL RESEARCH COLLABORATIONS As a prelude to forging international collaborations in the field of cancer research, a provocative question workshop was organized in AIIMS, New Delhi on 29th October 2014 under the aegis of DBT & NCI-USA The workshop focused on the importance of international collaborations in medical research and aimed at highlighting important areas of cancer research that are understudied or forgotten The workshop was moderated by Prof E D Harlow, Ludwig Professor of Cancer Research and Teaching, Harvard Medical School and senior advisor to the Director, NCI and was attended by delegates from NCI-USA, NIH-USA, AIIMS, DBT, ICPO, etc.

16 PROVOCATIVE QUESTION WORKSHOP: KEY DELIBERATIONS Priority areas for Prospective Collaboration Research Perspectives in India-Centric Cancers Breast Cancer Tobacco-related Cancers Carcinoma Gall Bladder Hematological malignancies Carcinoma Lung Carcinoma Cervix Changing Paradigms of Indian Perspective on International Collaboration US Perspective on Collaboration in Medical Research with India

17 INDO-US COLLABORATION IN CANCER RESEARCH Prof Harold Varmus, Director of National Cancer Institute, USA met Hon'ble Prime Minister of India during his visit to USA in September 2014, wherein it was decided to develop collaborative programmes for and with the National Cancer Institute of AIIMS, New Delhi and to initiate cooperative activities in cancer research This was also reflected in the joint statement issued on 30th September 2014 upon the conclusion of meeting between Prime Minister and President Obama

18 PROPOSED INDO-US COLLABORATION IN CANCER RESEARCH The main areas of cooperation proposed in the MoU between NCI(USA)-DBT-AIIMS are as follows: Development of a common set of health interventions which are scalable across economies, regions and population groups Development of common models in the areas of basic research, pre-clinical model development, clinical research and oncology care delivery Development of common controlled resources for basic research, clinical research and oncology care delivery Organization of joint conferences, symposia, or other scientific meetings of mutual interest Application of Nano-technology in Cancer Management It is proposed to have the formal signing of the said MoU during the visit of President Obama to India in January 2015

19 COLLABORATION WITH OHSL - AREAS OF INTEREST Translational Research in India-Centric Cancers Co-design and co-develop state of the art facilities like bio-bank, labs, etc. at National Cancer Institute, Jhajjar Exchange visits to impart training and orientation the AIIMS Faculty and Scientists in newer procedues and protocols which can be established at NCI-AIIMS Organization of joint conferences, symposia, or other scientific meetings of mutual interest

20 PROPOSED BY OHSL Cancer Prevention Use of traditional medicines for cancer control Use of complementary methodology such as yoga for patient care Drug discovery - India specific cancers Natural sources - traditional medicines Ayurvedic medicines - scientific underpinning Synthetics - Approved drugs – repurpose Radiation sensitizers Pre-clinical research - evaluation of agents in HTS (high throughput screening) In vitro and in vivo models for efficacy testing First in human studies Drug development Facility for making Phase I clinical product Phase I clinical research



Similar presentations

Ads by Google